Saizen 8.8 mg (Somatropin) is a recombinant human growth hormone designed for the treatment of growth hormone deficiency (GHD) in both children and adults. Each vial contains 8.8 mg (approximately 26.4 IU) of somatropin, a bio-identical form of natural GH that supports tissue growth, metabolism, and recovery. The lyophilized powder must be reconstituted with bacteriostatic water and administered via subcutaneous injection. Clinically, Saizen helps stimulate linear growth in pediatric patients and improves body composition, muscle mass, and energy levels in adults with GHD. Manufactured by EMD Serono, it is recognized for its purity, safety, and reliable performance in hormone replacement therapy.